Catalyst Wire Dossier Catalyst Wire Dossier

Verteporfin photodynamic therapy

verteporfin · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Verteporfin photodynamic therapy, covering 2014-03-19 to 2014-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration [Phase 3]

See pricing